BIOLOGICAL PRODUCTS-DRUG PRICE

Creates the Prescription Drug Pricing Transparency Act. Requires health insurers to disclose certain rate and spending information concerning prescription drugs and certain prescription drug pricing information to the Department of Public Health. Requires the Department and health insurers to create annual lists of prescription drugs on which the State spends significant health care dollars and for which costs have increased at a certain rate over time. Requires the Department and health insurers to provide their lists to the Attorney General. Requires prescription drug manufacturers to notify the Attorney General if they are introducing a new prescription drug at a wholesale acquisition cost that exceeds the threshold set for a specialty drug under the Medicare Part D program. Amends the Illinois Insurance Code. Requires a group or individual policy of accident and health insurance that provides coverage for prescription drugs to apply the same cost-sharing requirements to interchangeable biological products as apply to generic drugs under the policy. Amends the Pharmacy Practice Act. Provides that when a pharmacist receives a prescription for a biological product, the pharmacist shall select the lowest priced interchangeable biological product (rather than allowing a pharmacist to substitute an interchangeable biological product only if certain requirements are met). Requires that when a pharmacist receives a prescription from a Medicaid recipient, the pharmacist shall select the preferred drug or biological product from the State's preferred drug list. Makes other changes. Makes conforming changes in the Freedom of Information Act. Effective immediately. House Committee Amendment No. 1 Deletes reference to: 215 ILCS 5/356z.33 225 ILCS 85/16d new 225 ILCS 85/19.5 225 ILCS 85/19.7 new 225 ILCS 85/25 225 ILCS 85/41 Removes the provisions amending the Illinois Insurance Code and the Pharmacy Practice Act. State Mandates Fiscal Note, House Committee Amendment No. 1 (Dept. of Commerce & Economic Opportunity) This bill does not create a State mandate. Senate Floor Amendment No. 3 Deletes reference to: New Act 5 ILCS 140/7.5 Adds reference to: 625 ILCS 57/33 new 625 ILCS 57/Act title 625 ILCS 57/1 625 ILCS 57/5 625 ILCS 57/10 625 ILCS 57/15 625 ILCS 57/20 625 ILCS 57/25 625 ILCS 57/30 625 ILCS 57/32 625 ILCS 57/34 Replaces everything after the enacting clause. Reenacts the Transportation Network Providers Act. Provides for the continuation and validation of the Act, and extends the repeal to June 1, 2021. Effective immediately.